Molecular features of human pathological tau distinguish tauopathy-associated dementias - PubMed
3 months ago
- #tauopathy
- #neurodegenerative diseases
- #biomarkers
- Pathological tau protein in Alzheimer's disease (AD) accumulates post-translational modifications (PTMs), reflecting disease severity and progression.
- FLEXITau, a quantitative mass spectrometry-based proteomics platform, was used to analyze tau protein from 203 human subjects across various neurodegenerative diseases.
- Distinct molecular features of pathological tau were identified for each disease, enabling molecular disease stratification.
- The study identifies potential disease-specific biomarkers and therapeutic targets for tauopathies.
- Findings provide critical quantitative information for pharmacokinetic modeling in therapeutic and disease mechanism studies.